Associate Professor
Maastricht University
Maastricht, Limburg, Netherlands
After obtaining my Master’s degree in Biomedical Sciences magna cum laude at Hasselt University (Belgium), I started my PhD focusing on the effects of diet on “peripheral” vascular function and metabolic health in humans. During my PhD, I have developed as an independent researcher and became the expert and contact of vascular function measurements within the Metabolic Research Unit Maastricht (MRUM). My ultimate goal is to become a leading scientist in the field of translational nutrition, primarily focusing on conditions related to the human vasculature. In order to reach this goal, I decided to visit the internationally highly recognized Center for Functional MRI at the University of California, San Diego (United States). As a visiting graduate student, I learned advanced magnetic resonance imaging methodologies used for the non-invasive assessment of “brain” vascular function and metabolism.
After successfully defending my PhD in 2016, my research is focused on well-controlled trials assessing the effects of novel lifestyle and dietary approaches on vascular function and metabolic health in the periphery as well as in the brain, and cognitive/functional endpoints. For this, I apply novel vascular and magnetic resonance imaging methodologies (at the Scannexus research facilities) to assess brain health factors in fasting conditions, but also in response to a challenge, including intranasal insulin administration (brain insulin sensitivity), stress or tolerance tests. This approach already resulted in various successful research projects under my supervision providing evidence that new-concepts for healthy living play an instrumental role in improving brain health and cognitive performance, thereby contributing to the prevention of (global) cognitive impairment and promoting healthy aging.
Monday, July 27, 2026
9:30 AM - 10:15 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Monday, July 27, 2026
3:30 PM - 3:42 PM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.